لأحكام التجارية القوية للاتحاد الأوروبي حول الملكية الفكرية تعتبر تهديدا على نفاذ البلدان الفقيرة إلى الأدوية 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment ابروكسل- إن الجهود التي يبذلها الاتحاد الأوروبي لإدراج أحكام حول براءات المستحضرات الصيدلانية في سلسلة من اتفاقات التجارة الحرة التي يتفاوض حولها قد تشكل تهديدا على إمكانية الحصول على الأدوية في البلدان النامية، على حد قول الناشطين في مجال الصحة العامة على الصعيد العالمي.
Des dispositions renforçant la propriété intellectuelle dans certains accords de l’UE menacent l’accès aux médicaments dans les pays pauvres 24/02/2009 by David Cronin for Intellectual Property Watch Leave a Comment BRUXELLES – Selon certains activistes de la santé publique mondiale, les efforts de l’Union européenne (UE) pour intégrer des dispositions sur les brevets pharmaceutiques dans un certain nombre d’accords de libre échange en cours de négociation pourraient mettre en péril l’accès aux médicaments dans les pays en développement.
Las estrictas disposiciones comerciales de la UE sobre PI representan una amenaza para el acceso de los países pobres a los medicamentos 24/02/2009 by David Cronin for Intellectual Property Watch 1 Comment BRUSELAS- Los esfuerzos de la Unión Europea para introducir disposiciones firmes en materia de patentes farmacéuticas en una serie de acuerdos de libre comercio que está negociando podrían poner en peligro el acceso a los medicamentos en los países en desarrollo, según han afirmado activistas de la salud pública a nivel mundial.
Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access 18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged. As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
IP From Publicly Funded Research Should Benefit The Public, Experts Say 16/01/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment By Catherine Saez Publicly funded research institutions are major players in the area of life sciences and policies on the management of intellectual property emanating from this research have to be defined, according to speakers at a recent symposium in Geneva. The symposium on public sector IP management in the life sciences, held at the […]
Revised Chinese Patent Law Aims At Quality, Compulsory Licensing 15/01/2009 by Jia Hepeng for Intellectual Property Watch 1 Comment By Jia Hepeng and Yuan Yue for Intellectual Property Watch BEIJING – China’s newly revised patent law could create a more favourable environment for foreign companies to do research in the country, though measures are still needed to implement the law more effectively, according to some legal experts. The updated law also strengthens the government’s […]
Interest in China, Climate Change Arises From Different Sectors 23/12/2008 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara The importance of the Chinese economy as both a manufacturing giant and, increasingly, as a consumer of manufactured goods makes it clear that the country must play a key role in simultaneous global efforts to combat the threat of climate change and end the current financial crisis, a group of assembled delegates […]
An Alternative Proposal For Enhancing Developing Country Access To Patented Medicines 10/12/2008 by Wagdy Sawahel for Intellectual Property Watch Leave a Comment By Wagdy Sawahel for Intellectual Property Watch An intellectual property model intended to preserve the structure of patent protection while adding balance for developing countries has been proposed to provide incentives for innovators to contribute toward the alleviation of suffering in developing countries in dire need of patented medicines largely owned by rich countries. This […]
IP Roadmap Aims At Facilitating Technology Transfer In The Arab World 28/11/2008 by Wagdy Sawahel for Intellectual Property Watch Leave a Comment By Wagdy Sawahel for Intellectual Property Watch An intellectual property “roadmap” for the Arab world has been proposed for facilitating technology transfer as well as the adaptation of acquired technologies to local needs and contributing to the evolution of new technologies and their transfer to the marketplace. This IP roadmap was announced at the two-day […]
Ministers, Stakeholders Meet In Mali To Strategise On Health Research Systems 20/11/2008 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara Ministers of health, science and technology, and social development met this week with scientific researchers and representatives from foundations, the private sector and civil society to discuss the future of research for health on diseases disproportionately affecting the developing world. “Data matters, and the sharing of data matters,” Mark Walport, director of […]